Comparative evaluation of body mass index among school children with and without Bruxism of age group of 6-12 years in Kanchipuram district: A cross-sectional study.

AIM: To evaluate and compare the body mass index (BMI) of school-going children with bruxism and without bruxism of age between 6 and 12 years. SETTINGS AND DESIGN: To find the correlation between BMI and oral habit bruxism among school children and compare with those children without bruxism. MATERIALS AND METHODS: A total of 6122 children were screened from 28 government and 12 private schools, in which 1854 (30.28%) had various types of oral habits. Among this 280 children had the stressful habit bruxism. The BMI of those children was calculated by measuring the height and weight. The values were compared with the BMI of same number of students of same age group, who does not have any oral habits, with the WHO standard. The values were calculated and tabulated for the statistical analysis, using the SPSS software version 19 (IBM company) with the P < 0.05 as statistically significant. RESULTS: Its shows that children with bruxism has high BMI range, was in the order of overweight > Normal > Underweight, but the BMI of children without any habit was in the order of normal > Underweight > Overweight. On comparison, it was statistically significant. CONCLUSION: The habit bruxism had a positive correlation with the BMI of children. The children are more stressed from both indoor and outdoor. Hence, kindly educate all the parents, teachers, and public to identify the cause for the habit, because each oral habit is strongly deep rooted with some emotional and/or psychological problem and to make the children stress free in future.

Utility of Precision Medicine in the Management of Diabetes: Expert Opinion from an International Panel.

AIM: The primary objective of this review is to develop a practice-based expert group opinion on the role of precision medicine with a specific focus on sulfonylureas (SUs) in diabetes management. BACKGROUND: The clinical etiology, presentation and complications of diabetes vary from one patient to another, making the management of the disease challenging. The pre-eminent feature of diabetes mellitus (DM) are chronically elevated blood glucose concentrations; however, in clinical practice, the exclusion of autoimmunity, pregnancy, pancreatic disease or injury and rare genetic forms of diabetes is crucial. Within this framework, precision medicine provides unique insights into the risk factors and natural history of DM. Precision medicine goes beyond genomics and encompasses patient-centered care, molecular technologies and data sharing. Precision medicine has evolved in the field of diabetology. It has helped improve the efficacy of SUs, a class of drugs, which have been effectively used in the management of diabetes mellitus for decades, and it has enabled the expansion of SUs use in diabetes patients with genetic mutations. REVIEW RESULTS: After due discussions, the expert group analyzed studies that focused on the use of SUs in diabetes patients with genomic variations and rare mutations. The expert group opined that SUs are important glucose-lowering drugs and that precision medicine helps in improving the efficacy of SUs by matching them to those patients who will benefit most. CONCLUSION: Precision medicine opens new vistas for the effective use of SUs in unexpected patient populations, such as those with genetic mutations.